One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis | Zendy

Howard C. Herrmann | Zendy; Vinod H. Thourani | Zendy; Susheel Kodali | Zendy; Raj Makkar | Zendy; Wilson Y. Szeto | Zendy; Saif Anwaruddin | Zendy; Nimesh D. Desai | Zendy; Scott Lim | Zendy; S. Chris Malaisrie | Zendy; Dean J. Kereiakes | Zendy; Steven Ramee | Zendy; Kevin L. Greason | Zendy; Samir Kapadia | Zendy; Vasilis Babaliaros | Zendy; Rebecca T. Hahn | Zendy; Philippe Pîbarot | Zendy; Neil J. Weissman | Zendy; Jonathon Leipsic | Zendy; Brian Whisenant | Zendy; John G. Webb | Zendy; Michael J. Mack | Zendy; Martin B. Leon | Zendy

Open Access

One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis

Author(s) -

Howard C. Herrmann,

Vinod H. Thourani,

Susheel Kodali,

Raj Makkar,

Wilson Y. Szeto,

Saif Anwaruddin,

Nimesh D. Desai,

Scott Lim,

S. Chris Malaisrie,

Dean J. Kereiakes,

Steven Ramee,

Kevin L. Greason,

Samir Kapadia,

Vasilis Babaliaros,

Rebecca T. Hahn,

Philippe Pîbarot,

Neil J. Weissman,

Jonathon Leipsic,

Brian Whisenant,

John G. Webb,

Michael J. Mack,

Martin B. Leon

Publication year - 2016

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.116.022797

Subject(s) - medicine , stenosis , cardiology , aortic valve stenosis , valve replacement , aortic valve replacement , aortic valve

In the initial PARTNER trial (Placement of Aortic Transcatheter Valves) of transcatheter aortic valve replacement for high-risk (HR) and inoperable patients, mortality at 1 year was 24% in HR and 31% in inoperable patients. A recent report of the 30-day outcomes with the low-profile SAPIEN 3 transcatheter aortic valve replacement system demonstrated very low rates of adverse events, but little is known about the longer-term outcomes with this device.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research